These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30692330)

  • 41. [A case of advanced rectal cancer with severe liver dysfunction due to multiple liver metastases].
    Higuchi T; Ishikawa T; Tsukamoto S; Fujimori Y; Oda G; Okazaki S; Ishiguro M; Kobayashi H; Iida S; Uetake H; Yasuno M; Enomoto M; Sugihara K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2181-3. PubMed ID: 20037363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unresectable hepatic colorectal metastases: need for new surgical strategies.
    Vauthey JN; Abdalla EK
    Ann Surg Oncol; 2006 Jan; 13(1):5-6. PubMed ID: 16372151
    [No Abstract]   [Full Text] [Related]  

  • 43. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
    Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
    Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A Case of Chemotherapy with FOLFOXIRI plus Cetuximab for Liver Metastasis of Sigmoid Colon Cancer].
    Saito A; Konishi K; Fukunaga M; Takiguchi N; Nakai S; Honda S; Yukimoto R; Okamoto A; Takeoka T; Matsuno H; Okada K; Ota H; Yokoyama S; Konishi M; Kobayashi K
    Gan To Kagaku Ryoho; 2018 Mar; 45(3):507-509. PubMed ID: 29650920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy and molecular-targeted treatment for unresectable hepatic metastases: a Japanese perspective.
    Shimada Y
    J Hepatobiliary Pancreat Sci; 2012 Sep; 19(5):515-22. PubMed ID: 22588204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.
    Goéré D; Deshaies I; de Baere T; Boige V; Malka D; Dumont F; Dromain C; Ducreux M; Elias D
    Ann Surg; 2010 Apr; 251(4):686-91. PubMed ID: 20224373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful right hepatectomy after four treatments of yttrium-90 microspheres (SIR-Spheres) and concomitant FOLFOX as bridging therapy to resection of colorectal liver metastases.
    Chua TC; Bester L; Akther J; Morris DL
    Anticancer Res; 2010 Jul; 30(7):3005-7. PubMed ID: 20683046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oncologic emergencies secondary to advanced colorectal cancer successfully treated with oxaliplatin/5-fluorouracil/leucovorin: report of three cases.
    Cavanna L; Bertè R; Bidin L; Civardi G; Anselmi E; Lazzaro A; Moroni CF; Palladino MA; Rodinò C; Vallisa D
    J Chemother; 2005 Jun; 17(3):334-8. PubMed ID: 16038529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hepatic resection after neoadjuvant therapy for initially unresectable colorectal liver metastases].
    Kaibori M; Iwamoto S; Ishizaki M; Matsui K; Saito T; Yoshioka K; Kwon AH
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2579-82. PubMed ID: 20009458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer.
    Masi G; Cupini S; Marcucci L; Cerri E; Loupakis F; Allegrini G; Brunetti IM; Pfanner E; Viti M; Goletti O; Filipponi F; Falcone A
    Ann Surg Oncol; 2006 Jan; 13(1):58-65. PubMed ID: 16372158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. mFOLFOX6 Plus Panitumumab Versus 5-FU/LV Plus Panitumumab After Six Cycles of Frontline mFOLFOX6 Plus Panitumumab: A Randomized Phase II Study of Patients With Unresectable or Advanced/Recurrent, RAS Wild-type Colorectal Carcinoma (SAPPHIRE)-Study Design and Rationale.
    Nagata N; Mishima H; Kurosawa S; Oba K; Sakamoto J
    Clin Colorectal Cancer; 2017 Jun; 16(2):154-157.e1. PubMed ID: 28284575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983.
    Tanis E; Julié C; Emile JF; Mauer M; Nordlinger B; Aust D; Roth A; Lutz MP; Gruenberger T; Wrba F; Sorbye H; Bechstein W; Schlag P; Fisseler A; Ruers T
    Eur J Cancer; 2015 Nov; 51(17):2708-17. PubMed ID: 26342674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Two-stage hepatectomy combined with converting chemotherapy achieved a successful treatment for initially unresectable multiple bilobar colorectal liver metastases].
    Ueda A; Yoshidome H; Kagawa S; Kimura F; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Suda K; Takano S; Kuboki S; Miyazaki M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2557-9. PubMed ID: 21224638
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study.
    Leone F; Artale S; Marino D; Cagnazzo C; Cascinu S; Pinto C; Fornarini G; Tampellini M; Di Fabio F; Sartore-Bianchi A; De Carlis L; Pugliese R; Capussotti L; Gioeni L; Siena S; Aglietta M
    Cancer; 2013 Oct; 119(19):3429-35. PubMed ID: 23868516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.
    Lorenz M; Staib-Sebler E; Gog C; Proschek D; Jauch KW; Ridwelski K; Hohenberger W; Gassel HJ; Lehmann U; Vestweber KH; Padberg W; Zamzow K; Müller HH
    Zentralbl Chir; 2003 Feb; 128(2):87-94. PubMed ID: 12632273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Three cases of multiple colorectal liver metastases responding to hepatic arterial infusion chemotherapy undergoing liver resection].
    Kobayashi K; Ueki K; Ishizuka D; Wakakuwa R
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):389-91. PubMed ID: 15791824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Liver resection after downstaging with neoadjuvant chemotherapy for "unresectable" colorectal metastases].
    Frena A; Martin F; La Guardia G; Vezzali N; Bonatti G; Stocker J; Graiff C
    Chir Ital; 2004; 56(3):351-7. PubMed ID: 15287631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A case of pathological complete response of metachronous multiple liver metastases from colorectal cancer after mFOLFOX+bevacizumab chemotherapy].
    Otsuka S; Inagaki M; Nishie M; Hamano R; Tokunaga N; Takahashi K; Tsunemitsu Y; Miyoshi K; Iwakawa K; Takahashi M; Iwagak H
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2166-8. PubMed ID: 20037358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Results of neo-adjuvant chemotherapy by FOLFOX and FOLFIRI for colorectal liver metastasis].
    Amano R; Yamada N; Noda E; Kubo N; Tanaka H; Muguruma K; Inoue T; Yashiro M; Maeda K; Onoda N; Sawada T; Nakata B; Ohira M; Ishikawa T; Hirakawa K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2003-5. PubMed ID: 20037305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A curative resection with the combination of portal vein branch embolization and systemic chemotherapy in a patient with synchronous multiple and bilobar colorectal liver metastases].
    Iida A; Yoshidome H; Kaneko T; Shimizu K; Mishima T; Muto T; Miyazaki M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2190-2. PubMed ID: 20037366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.